TGFB1 and neoplasm: SOX4 is a prominent tumor-related transcription factor and its expression is increased in multitude of human cancers, and has been demonstrated to participant in the TGF-β induced EMT, a process closely associated with increases in migrative and invasive capacity, in metastasis and in chemotherapy drug resistance [14, 39, 40].